Clear cell hidradenoma of the skin - a third tumor type with a t(11;19)-associated TORC1-MAML2 gene fusion
(2005) In Genes, Chromosomes and Cancer 43(2). p.202-205- Abstract
- Recent studies have shown that the t(11;19)(q21;p13) translocation in mucoepidermoid carcinomas and benign Warthin's tumors results in a fusion of the N-terminal CREB-binding domain of the cAMP coactivator TORCI (a.k.a. MECT1 and WAMTP1) to the Notch coactivator MAML2. Here we show that a third tumor type, clear cell hidradenoma of the skin, also expresses this gene fusion. RT-PCR analysis of a clear cell hidradenoma with at(11;19)(q21;p13) translocation revealed expression of a TORC1-MAML2 fusion transcript consisting of exon 1 of TORC1 fused to exons 2-5 of MAML2. Because the fusion was only detected in a single case, the frequency of this aberration in clear cell hidradenomas remains unknown. These results demonstrate that the t(11; 19)... (More)
- Recent studies have shown that the t(11;19)(q21;p13) translocation in mucoepidermoid carcinomas and benign Warthin's tumors results in a fusion of the N-terminal CREB-binding domain of the cAMP coactivator TORCI (a.k.a. MECT1 and WAMTP1) to the Notch coactivator MAML2. Here we show that a third tumor type, clear cell hidradenoma of the skin, also expresses this gene fusion. RT-PCR analysis of a clear cell hidradenoma with at(11;19)(q21;p13) translocation revealed expression of a TORC1-MAML2 fusion transcript consisting of exon 1 of TORC1 fused to exons 2-5 of MAML2. Because the fusion was only detected in a single case, the frequency of this aberration in clear cell hidradenomas remains unknown. These results demonstrate that the t(11; 19) in mucoepidermoid carcinoma, Warthin's tumor, and clear cell hidradenoma targets the same genes and results in identical gene fusions, indicating that at least subgroups of these glandular tumors evolve through activation of the same molecular pathways. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/245793
- author
- Behboudi, A ; Winnes, M ; Gorunova, Ludmila LU ; van den Oord, J J ; Mertens, Fredrik LU ; Enlund, F and Stenman, G
- organization
- publishing date
- 2005
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Genes, Chromosomes and Cancer
- volume
- 43
- issue
- 2
- pages
- 202 - 205
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- wos:000228532200010
- pmid:15729701
- scopus:17044384692
- ISSN
- 1045-2257
- DOI
- 10.1002/gcc.20168
- language
- English
- LU publication?
- yes
- id
- b3d617f2-fb26-4f35-81af-29e4b58ad77e (old id 245793)
- date added to LUP
- 2016-04-01 12:28:25
- date last changed
- 2022-04-13 19:28:06
@article{b3d617f2-fb26-4f35-81af-29e4b58ad77e, abstract = {{Recent studies have shown that the t(11;19)(q21;p13) translocation in mucoepidermoid carcinomas and benign Warthin's tumors results in a fusion of the N-terminal CREB-binding domain of the cAMP coactivator TORCI (a.k.a. MECT1 and WAMTP1) to the Notch coactivator MAML2. Here we show that a third tumor type, clear cell hidradenoma of the skin, also expresses this gene fusion. RT-PCR analysis of a clear cell hidradenoma with at(11;19)(q21;p13) translocation revealed expression of a TORC1-MAML2 fusion transcript consisting of exon 1 of TORC1 fused to exons 2-5 of MAML2. Because the fusion was only detected in a single case, the frequency of this aberration in clear cell hidradenomas remains unknown. These results demonstrate that the t(11; 19) in mucoepidermoid carcinoma, Warthin's tumor, and clear cell hidradenoma targets the same genes and results in identical gene fusions, indicating that at least subgroups of these glandular tumors evolve through activation of the same molecular pathways.}}, author = {{Behboudi, A and Winnes, M and Gorunova, Ludmila and van den Oord, J J and Mertens, Fredrik and Enlund, F and Stenman, G}}, issn = {{1045-2257}}, language = {{eng}}, number = {{2}}, pages = {{202--205}}, publisher = {{John Wiley & Sons Inc.}}, series = {{Genes, Chromosomes and Cancer}}, title = {{Clear cell hidradenoma of the skin - a third tumor type with a t(11;19)-associated TORC1-MAML2 gene fusion}}, url = {{http://dx.doi.org/10.1002/gcc.20168}}, doi = {{10.1002/gcc.20168}}, volume = {{43}}, year = {{2005}}, }